Although galantamine has reported effects on other neurotransmitters, e.g., dopamine and serotonin, which may have beneficial actions on pancreatic function and pancreatitis (Han et al. 2017; Owyang and Logsdon 2004), these effects may be secondary to potentiating effects on nAChR function, particularly presynaptically via the α7nAChR, a possibility which is ruled out by the nAChR antagonists employed and the gene KO experiments. The gene discussed is CHRNA4; the disease is pancreatitis.